{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:46:14Z","timestamp":1793724374482,"version":"4.6.1"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12035-021-02387-w","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T07:07:56Z","timestamp":1618902476000},"page":"3903-3917","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Sirtuin Acetylation and Deacetylation: a Complex Paradigm in Neurodegenerative Disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Heena","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarjot","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"2387_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-5-5-485","volume":"5","author":"A Vassilopoulos","year":"2011","unstructured":"Vassilopoulos A, Fritz KS, Petersen DR, Gius D (2011) The human sirtuin family: evolutionary divergences and functions. Hum Genom 5:1\u201312. https:\/\/doi.org\/10.1186\/1479-7364-5-5-485","journal-title":"Hum Genom"},{"key":"2387_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1124\/pr.110.003905","volume":"64","author":"C Cant\u00f3","year":"2012","unstructured":"Cant\u00f3 C, Auwerx J (2012) Targeting sirtuin 1 to improve metabolism: all you need is NAD+? Pharmacol Rev 64:166\u2013187. https:\/\/doi.org\/10.1124\/pr.110.003905","journal-title":"Pharmacol Rev"},{"key":"2387_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ejmech.2018.10.028","volume":"161","author":"Y Wang","year":"2019","unstructured":"Wang Y, He J, Liao M, Hu M, Li W, Ouyang H, Wang X, Ye T et al (2019) An overview of Sirtuins as potential therapeutic target: structure, function and modulators. Eur J Med Chem 161:48\u201377. https:\/\/doi.org\/10.1016\/j.ejmech.2018.10.028","journal-title":"Eur J Med Chem"},{"key":"2387_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3988\/jcn.2009.5.3.120","volume":"5","author":"SH Han","year":"2009","unstructured":"Han SH (2009) Potential role of sirtuin as a therapeutic target for neurodegenerative diseases. J Clin Neurol 5:120\u2013125. https:\/\/doi.org\/10.3988\/jcn.2009.5.3.120","journal-title":"J Clin Neurol"},{"key":"2387_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.tips.2019.09.003","volume":"40","author":"P Gomes","year":"2019","unstructured":"Gomes P, Leal H, Mendes AF, Reis F, Cavadas C (2019) Dichotomous sirtuins: implications for drug discovery in neurodegenerative and cardiometabolic diseases. Trends Pharmacol Sci 40:1021\u20131039. https:\/\/doi.org\/10.1016\/j.tips.2019.09.003","journal-title":"Trends Pharmacol Sci"},{"key":"2387_CR6","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/cr.2013.70","volume":"23","author":"AZ Herskovits","year":"2013","unstructured":"Herskovits AZ, Guarente L (2013) Sirtuin deacetylases in neurodegenerative diseases of aging. Cell Res 23:746\u2013758. https:\/\/doi.org\/10.1038\/cr.2013.70","journal-title":"Cell Res"},{"key":"2387_CR7","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cophys.2018.03.011","volume":"3","author":"MA Walker","year":"2018","unstructured":"Walker MA, Tian R (2018) NAD(H) in mitochondrial energy transduction: implications for health and disease. Curr Opin Physiol 3:101\u2013109. https:\/\/doi.org\/10.1016\/j.cophys.2018.03.011","journal-title":"Curr Opin Physiol"},{"key":"2387_CR8","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s00125-019-4831-3","volume":"62","author":"NJ Connell","year":"2019","unstructured":"Connell NJ, Houtkooper RH, Schrauwen P (2019) NAD+ metabolism as a target for metabolic health: have we found the silver bullet? Diabetologia 62:888\u2013899. https:\/\/doi.org\/10.1007\/s00125-019-4831-3","journal-title":"Diabetologia"},{"key":"2387_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","volume":"22","author":"C Canto","year":"2015","unstructured":"Canto C, Menzies KJ, Auwerx J (2015) NAD+ metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab 22:31\u201353. https:\/\/doi.org\/10.1016\/j.cmet.2015.05.023","journal-title":"Cell Metab"},{"key":"2387_CR10","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2017.08.027","volume":"265","author":"B Sosnowska","year":"2017","unstructured":"Sosnowska B, Mazidi M, Penson P, Gluba-Brz\u00f3zka A, Rysz J, Banach M (2017) The sirtuin family members SIRT1, SIRT3 and SIRT6: their role in vascular biology and atherogenesis. Atherosclerosis 265:275\u2013282. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.08.027","journal-title":"Atherosclerosis"},{"key":"2387_CR11","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1152\/physrev.00022.2011","volume":"92","author":"R Nogueiras","year":"2012","unstructured":"Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, Horvath TL, Sinclair DA et al (2012) Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 92:1479\u20131514. https:\/\/doi.org\/10.1152\/physrev.00022.2011","journal-title":"Physiol Rev"},{"key":"2387_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.bbrc.2008.08.137","volume":"376","author":"B Zschoernig","year":"2008","unstructured":"Zschoernig B, Mahlknecht U (2008) SIRTUIN 1: regulating the regulator. Biochem Biophys Res Commun 376:251\u2013255. https:\/\/doi.org\/10.1016\/j.bbrc.2008.08.137","journal-title":"Biochem Biophys Res Commun"},{"key":"2387_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molmed.2010.09.005","volume":"17","author":"MP Gillum","year":"2011","unstructured":"Gillum MP, Erion DM, Shulman GI (2011) Sirtuin-1 regulation of mammalian metabolism. Trends Mol Med 17:8\u201313. https:\/\/doi.org\/10.1016\/j.molmed.2010.09.005","journal-title":"Trends Mol Med"},{"key":"2387_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1447-0594.2008.00504.x","volume":"9","author":"L Zeng","year":"2009","unstructured":"Zeng L, Chen R, Liang F, Tsuchiya H, Murai H, Nakahashi T, Iwai K, Takahashi T et al (2009) Silent information regulator, Sirtuin 1, and age-related diseases. Geriatr Gerontol Int 9:7\u201315. https:\/\/doi.org\/10.1111\/j.1447-0594.2008.00504.x","journal-title":"Geriatr Gerontol Int"},{"key":"2387_CR15","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/biof.1032","volume":"38","author":"JM Villalba","year":"2012","unstructured":"Villalba JM, Alca\u00edn FJ (2012) Sirtuin activators and inhibitors. Biofactors 38:349\u2013359. https:\/\/doi.org\/10.1002\/biof.1032","journal-title":"Biofactors"},{"key":"2387_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s13311-013-0214-5","volume":"10","author":"B Langley","year":"2013","unstructured":"Langley B, Sauve A (2013) Sirtuin deacetylases as therapeutic targets in the nervous system. Neurotherapeutics 10:605\u2013620. https:\/\/doi.org\/10.1007\/s13311-013-0214-5","journal-title":"Neurotherapeutics"},{"key":"2387_CR17","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.tips.2015.08.001","volume":"36","author":"P Gomes","year":"2015","unstructured":"Gomes P, Outeiro TF, Cavadas C (2015) Emerging role of sirtuin 2 in the regulation of mammalian metabolism. Trends Pharmacol Sci 36:756\u2013768. https:\/\/doi.org\/10.1016\/j.tips.2015.08.001","journal-title":"Trends Pharmacol Sci"},{"key":"2387_CR18","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/cvr\/cvq250","volume":"88","author":"VB Pillai","year":"2010","unstructured":"Pillai VB, Sundaresan NR, Jeevanandam V, Gupta MP (2010) Mitochondrial SIRT3 and heart disease. Cardiovasc Res 88:250\u2013256. https:\/\/doi.org\/10.1093\/cvr\/cvq250","journal-title":"Cardiovasc Res"},{"key":"2387_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1101\/gad.1527307","volume":"21","author":"MB Scher","year":"2007","unstructured":"Scher MB, Vaquero A, Reinberg D (2007) SIRT3 is a nuclear NAD+-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev 21:920\u2013928. https:\/\/doi.org\/10.1101\/gad.1527307","journal-title":"Genes Dev"},{"key":"2387_CR20","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1471-4159.2005.03492.x","volume":"96","author":"TS Anekonda","year":"2006","unstructured":"Anekonda TS, Reddy PH (2006) Neuronal protection by sirtuins in Alzheimer\u2019s disease. J Neurochem 96:305\u2013313. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03492.x","journal-title":"J Neurochem"},{"key":"2387_CR21","doi-asserted-by":"publisher","first-page":"33583","DOI":"10.1074\/jbc.m705488200","volume":"282","author":"N Ahuja","year":"2007","unstructured":"Ahuja N, Schwer B, Carobbio S, Waltregny D, North BJ, Castronovo V, Maechler P, Verdin E (2007) Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 282:33583\u201333592. https:\/\/doi.org\/10.1074\/jbc.m705488200","journal-title":"J Biol Chem"},{"key":"2387_CR22","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.2147\/OTT.S157724","volume":"11","author":"G Huang","year":"2018","unstructured":"Huang G, Zhu G (2018) Sirtuin-4 (SIRT4), a therapeutic target with oncogenic and tumor-suppressive activity in cancer. Onco Targets Ther 11:3395. https:\/\/doi.org\/10.2147\/OTT.S157724","journal-title":"Onco Targets Ther"},{"key":"2387_CR23","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1139\/o10-010","volume":"88","author":"YR Chen","year":"2010","unstructured":"Chen YR, Fang SR, Fu YC, Zhou XH, Xu MY, Xu WC (2010) Calorie restriction on insulin resistance and expression of SIRT1 and SIRT4 in rats. Biochem Cell Biol 88:715\u2013722. https:\/\/doi.org\/10.1139\/o10-010","journal-title":"Biochem Cell Biol"},{"key":"2387_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.cmet.2013.11.013","volume":"18","author":"MJ Rardin","year":"2013","unstructured":"Rardin MJ, He W, Nishida Y, Newman JC, Carrico C, Danielson SR, Guo A, Gut P et al (2013) SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks. Cell Metab 18:920\u2013933. https:\/\/doi.org\/10.1016\/j.cmet.2013.11.013","journal-title":"Cell Metab"},{"key":"2387_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/368276","volume":"2011","author":"R Rajendran","year":"2011","unstructured":"Rajendran R, Garva R, Krstic-Demonacos M (2011) Demonacos C (2011) Sirtuins: molecular traffic lights in the crossroad of oxidative stress, chromatin remodeling, and transcription. J Biomed Biotechnol 2011:1\u201317. https:\/\/doi.org\/10.1155\/2011\/368276","journal-title":"J Biomed Biotechnol"},{"key":"2387_CR26","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1126\/science.1202723","volume":"332","author":"Z Mao","year":"2011","unstructured":"Mao Z, Hine C, Tian X, Van Meter M, Au M, Vaidya A, Seluanov A, Gorbunova V (2011) SIRT6 promotes DNA repair under stress by activating PARP1. Sci 332:1443\u20131446. https:\/\/doi.org\/10.1126\/science.1202723","journal-title":"Sci"},{"key":"2387_CR27","doi-asserted-by":"publisher","first-page":"14575","DOI":"10.1074\/jbc.m111.218990","volume":"286","author":"PW Pan","year":"2011","unstructured":"Pan PW, Feldman JL, Devries MK, Dong A, Edwards AM, Denu JM (2011) Structure and biochemical functions of SIRT6. J Biol Chem 286:14575\u201314587. https:\/\/doi.org\/10.1074\/jbc.m111.218990","journal-title":"J Biol Chem"},{"key":"2387_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s10522-017-9685-9","volume":"18","author":"W Grabowska","year":"2017","unstructured":"Grabowska W, Sikora E, Bielak-Zmijewska A (2017) Sirtuins, a promising target in slowing down the ageing process. Biogerontol 18:447\u2013476. https:\/\/doi.org\/10.1007\/s10522-017-9685-9","journal-title":"Biogerontol"},{"key":"2387_CR29","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1038\/nrd2665","volume":"7","author":"S Lavu","year":"2008","unstructured":"Lavu S, Boss O, Elliott PJ, Lambert PD (2008) Sirtuins\u2014novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov 7:841\u2013853. https:\/\/doi.org\/10.1038\/nrd2665","journal-title":"Nat Rev Drug Discov"},{"key":"2387_CR30","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1111\/j.1460-9568.2012.08150.x","volume":"35","author":"CM Rice","year":"2012","unstructured":"Rice CM, Sun M, Kemp K, Gray E, Wilkins A, Scolding NJ (2012) Mitochondrial sirtuins\u2014a new therapeutic target for repair and protection in multiple sclerosis. Eur J Neurosci 35:1887\u20131893. https:\/\/doi.org\/10.1111\/j.1460-9568.2012.08150.x","journal-title":"Eur J Neurosci"},{"key":"2387_CR31","first-page":"371","volume":"9","author":"PJ Elliott","year":"2008","unstructured":"Elliott PJ, Jirousek M (2008) Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs 9:371\u2013378","journal-title":"Curr Opin Investig Drugs"},{"key":"2387_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1947601912474931","volume":"4","author":"J Shih","year":"2013","unstructured":"Shih J, Donmez G (2013) Mitochondrial sirtuins as therapeutic targets for age-related disorders. Genes Cancer 4:91\u201396. https:\/\/doi.org\/10.1177\/1947601912474931","journal-title":"Genes Cancer"},{"key":"2387_CR33","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1242\/jcs.081067","volume":"124","author":"T Nakagawa","year":"2011","unstructured":"Nakagawa T, Guarente L (2011) Sirtuins at a glance. J Cell Sci 124:833\u2013838. https:\/\/doi.org\/10.1242\/jcs.081067","journal-title":"J Cell Sci"},{"key":"2387_CR34","doi-asserted-by":"publisher","first-page":"4000","DOI":"10.1007\/s00018-008-8357-y","volume":"65","author":"DM Taylor","year":"2008","unstructured":"Taylor DM, Maxwell MM, Luthi-Carter R, Kazantsev AG (2008) Biological and potential therapeutic roles of sirtuin deacetylases. Cell Mol Life Sci 65:4000\u20134018. https:\/\/doi.org\/10.1007\/s00018-008-8357-y","journal-title":"Cell Mol Life Sci"},{"key":"2387_CR35","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neubiorev.2016.11.022","volume":"73","author":"M Ajami","year":"2017","unstructured":"Ajami M, Pazoki-Toroudi H, Amani H, Nabavi SF, Braidy N, Vacca RA, Atanasov AG, Mocan A et al (2017) Therapeutic role of sirtuins in neurodegenerative disease and their modulation by polyphenols. Neurosci Biobehav Rev 73:39\u201347. https:\/\/doi.org\/10.1016\/j.neubiorev.2016.11.022","journal-title":"Neurosci Biobehav Rev"},{"key":"2387_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3389\/fphar.2012.00082","volume":"3","author":"R Machado De Oliveira","year":"2012","unstructured":"Machado De Oliveira R, Sarkander J, Kazantsev AG, Outeiro TF (2012) SIRT2 as a therapeutic target for age-related disorders. Front Pharmacol 3:82. https:\/\/doi.org\/10.3389\/fphar.2012.00082","journal-title":"Front Pharmacol"},{"key":"2387_CR37","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1007\/s11064-016-2110-y","volume":"42","author":"H J\u0119\u015bko","year":"2017","unstructured":"J\u0119\u015bko H, Wencel P, Strosznajder RP, Strosznajder JB (2017) Sirtuins and their roles in brain aging and neurodegenerative disorders. Neurochem Res 42:876\u2013890. https:\/\/doi.org\/10.1007\/s11064-016-2110-y","journal-title":"Neurochem Res"},{"key":"2387_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3389\/fnagi.2013.00016","volume":"5","author":"R Lalla","year":"2013","unstructured":"Lalla R, Donmez G (2013) The role of sirtuins in Alzheimer\u2019s disease. Front Aging Neurosci 5:16. https:\/\/doi.org\/10.3389\/fnagi.2013.00016","journal-title":"Front Aging Neurosci"},{"key":"2387_CR39","doi-asserted-by":"publisher","first-page":"417","DOI":"10.4103\/1673-5374.228719","volume":"13","author":"DM Silberman","year":"2018","unstructured":"Silberman DM (2018) Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins. Neural Regen Res 13:417. https:\/\/doi.org\/10.4103\/1673-5374.228719","journal-title":"Neural Regen Res"},{"key":"2387_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1146\/annurev.pathol.4.110807.092250","volume":"5","author":"MC Haigis","year":"2010","unstructured":"Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Ann Rev Pathol: Mech Dis 5:253\u2013295. https:\/\/doi.org\/10.1146\/annurev.pathol.4.110807.092250","journal-title":"Ann Rev Pathol: Mech Dis"},{"key":"2387_CR41","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fnagi.2013.00053","volume":"5","author":"SW Min","year":"2013","unstructured":"Min SW, Sohn PD, Cho SH, Swanson RA, Gan L (2013) Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front Aging Neurosci 5:53. https:\/\/doi.org\/10.3389\/fnagi.2013.00053","journal-title":"Front Aging Neurosci"},{"key":"2387_CR42","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6:018713. https:\/\/doi.org\/10.1101\/cshperspect.a018713","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"13","key":"2387_CR43","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1038\/sj.emboj.7601758","volume":"26","author":"D Kim","year":"2007","unstructured":"Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer\u2019s disease and amyotrophic lateral sclerosis. EMBO J 26(13):3169\u20133179. https:\/\/doi.org\/10.1038\/sj.emboj.7601758","journal-title":"EMBO J"},{"issue":"12","key":"2387_CR44","doi-asserted-by":"publisher","first-page":"9100","DOI":"10.1074\/jbc.M109.060061","volume":"285","author":"V Vingtdeux","year":"2010","unstructured":"Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J et al (2010) AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-\u03b2 peptide metabolism. J Biol Chem 285(12):9100\u20139113. https:\/\/doi.org\/10.1074\/jbc.M109.060061","journal-title":"J Biol Chem"},{"issue":"8","key":"2387_CR45","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/s0891-5849(03)00062-5","volume":"34","author":"JH Jang","year":"2003","unstructured":"Jang JH, Surh YJ (2003) Protective effect of resveratrol on \u03b2-amyloid-induced oxidative PC12 cell death. Free Radic Biol Med 34(8):1100\u20131110. https:\/\/doi.org\/10.1016\/s0891-5849(03)00062-5","journal-title":"Free Radic Biol Med"},{"key":"2387_CR46","doi-asserted-by":"publisher","first-page":"8226","DOI":"10.3390\/ijms21218226","volume":"21","author":"H Liu","year":"2020","unstructured":"Liu H, Zhang Y, Zhang H, Xu S, Zhao H, Liu X (2020) A\u03b2-induced damage memory in hCMEC\/D3 cells mediated by Sirtuin-1. Int J Mol Sci 21:8226. https:\/\/doi.org\/10.3390\/ijms21218226","journal-title":"Int J Mol Sci"},{"key":"2387_CR47","doi-asserted-by":"publisher","first-page":"12679","DOI":"10.1111\/acel.12679","volume":"17","author":"J Lee","year":"2018","unstructured":"Lee J, Kim Y, Liu T, Hwang YJ, Hyeon SJ, Im H, Lee K, Alvarez VE et al (2018) SIRT3 deregulation is linked to mitochondrial dysfunction in Alzheimer\u2019s disease. Aging Cell 17:12679. https:\/\/doi.org\/10.1111\/acel.12679","journal-title":"Aging Cell"},{"issue":"13","key":"2387_CR48","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1016\/j.celrep.2017.03.008","volume":"18","author":"S Kaluski","year":"2017","unstructured":"Kaluski S, Portillo M, Besnard A, Stein D, Einav M, Zhong L, Ueberham U, Arendt T et al (2017) Neuroprotective functions for the histone deacetylase SIRT6. Cell Rep 18(13):3052\u20133062. https:\/\/doi.org\/10.1016\/j.celrep.2017.03.008","journal-title":"Cell Rep"},{"key":"2387_CR49","first-page":"P5. 011","volume":"84","author":"J Yin","year":"2015","unstructured":"Yin J, Han PC, Caselli R, Beach T, Serrano G, Reiman E, Shi J (2015) Sirtuin 3 is down-regulated in Apolipoprotein E4 carriers with Alzheimer\u2019s disease. Am Acad Neurol 84:P5. 011","journal-title":"Am Acad Neurol"},{"key":"2387_CR50","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/acel.12538","volume":"16","author":"A Ansari","year":"2017","unstructured":"Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim KH (2017) Function of the SIRT 3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell 16:4\u201316. https:\/\/doi.org\/10.1111\/acel.12538","journal-title":"Aging Cell"},{"key":"2387_CR51","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/jnr.23806","volume":"95","author":"BL Tang","year":"2017","unstructured":"Tang BL (2017) Sirtuins as modifiers of Parkinson\u2019s disease pathology. J Neurosci Res 95:930\u2013942. https:\/\/doi.org\/10.1002\/jnr.23806","journal-title":"J Neurosci Res"},{"key":"2387_CR52","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1523\/jneurosci.3442-11.2012","volume":"32","author":"G Donmez","year":"2012","unstructured":"Donmez G, Arun A, Chung CY, McLean PJ, Lindquist S, Guarente L (2012) SIRT1 protects against \u03b1-synuclein aggregation by activating molecular chaperones. J Neurosci 32:124\u2013132. https:\/\/doi.org\/10.1523\/jneurosci.3442-11.2012","journal-title":"J Neurosci"},{"key":"2387_CR53","doi-asserted-by":"publisher","first-page":"13","DOI":"10.29245\/2572.942X\/2017\/1.1168","volume":"3","author":"G Yalcin","year":"2018","unstructured":"Yalcin G (2018) Sirtuins and neurodegeneration. J Neurol Neuromed 3:13\u201320","journal-title":"J Neurol Neuromed"},{"issue":"5837","key":"2387_CR54","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, Volk CB, Maxwell MM et al (2007) Sirtuin 2 inhibitors rescue \u03b1-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 317(5837):516\u2013519. https:\/\/doi.org\/10.1126\/science.1143780","journal-title":"Science"},{"key":"2387_CR55","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of Sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"key":"2387_CR56","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.pnpbp.2008.03.024","volume":"32","author":"J Blanchet","year":"2008","unstructured":"Blanchet J, Longpr\u00e9 F, Bureau G, Morissette M, DiPaolo T, Bronchti G, Martinoli MG (2008) Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1243\u20131250. https:\/\/doi.org\/10.1016\/j.pnpbp.2008.03.024","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2387_CR57","doi-asserted-by":"publisher","unstructured":"Koike T, Suzuki K, Kawahata T (2012) SIRT2 (Sirtuin2)\u2014an emerging regulator of neuronal degeneration. Neurodegeneration 1. https:\/\/doi.org\/10.5772\/34722","DOI":"10.5772\/34722"},{"key":"2387_CR58","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11011-018-0330-3","volume":"34","author":"C Chen","year":"2019","unstructured":"Chen C, Xia B, Tang L, Wu W, Tang J, Liang Y, Yang H, Zhang Z et al (2019) Echinacoside protects against MPTP\/MPP+-induced neurotoxicity via regulating autophagy pathway mediated by Sirt1. Metab Brain Dis 34:203\u2013212. https:\/\/doi.org\/10.1007\/s11011-018-0330-3","journal-title":"Metab Brain Dis"},{"key":"2387_CR59","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3389\/fphar.2012.00042","volume":"3","author":"TL Spires-Jones","year":"2012","unstructured":"Spires-Jones TL, Fox LM, Rozkalne A, Pitstick R, Carlson GA, Kazantsev AG (2012) Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 3:42. https:\/\/doi.org\/10.3389\/fphar.2012.00042","journal-title":"Front Pharmacol"},{"key":"2387_CR60","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1471-4159.2009.06228.x","volume":"110","author":"D Albani","year":"2009","unstructured":"Albani D, Polito L, Batelli S, De Mauro S, Fracasso C, Martelli G, Colombo L, Manzoni C et al (2009) The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by \u03b1-synuclein or amyloid-\u03b2 (1-42) peptide. J Neurochem 110:1445\u20131456. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06228.x","journal-title":"J Neurochem"},{"key":"2387_CR61","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1007\/s11064-016-1892-2","volume":"41","author":"JY Zhang","year":"2016","unstructured":"Zhang JY, Deng YN, Zhang M, Su H, Qu QM (2016) SIRT3 acts as a neuroprotective agent in rotenone-induced Parkinson cell model. Neurochem Res 41:1761\u20131773. https:\/\/doi.org\/10.1007\/s11064-016-1892-2","journal-title":"Neurochem Res"},{"key":"2387_CR62","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40263-013-0055-0","volume":"27","author":"W Duan","year":"2013","unstructured":"Duan W (2013) Targeting sirtuin-1 in Huntington\u2019s disease: rationale and current status. CNS Drugs 27:345\u2013352. https:\/\/doi.org\/10.1007\/s40263-013-0055-0","journal-title":"CNS Drugs"},{"key":"2387_CR63","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.bbadis.2015.07.003","volume":"1852","author":"L Naia","year":"2015","unstructured":"Naia L, Rego AC (2015) Sirtuins: double players in Huntington\u2019s disease. Biochim Biophys Acta (BBA)-Mol Basis Dis 1852:2183\u20132194. https:\/\/doi.org\/10.1016\/j.bbadis.2015.07.003","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"2387_CR64","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vascn.2012.08.001","volume":"66","author":"Z Konsoula","year":"2012","unstructured":"Konsoula Z, Barile FA (2012) Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders. J Pharmacol Toxicol Methods 66:215\u2013220. https:\/\/doi.org\/10.1016\/j.vascn.2012.08.001","journal-title":"J Pharmacol Toxicol Methods"},{"key":"2387_CR65","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1002\/acn3.135","volume":"1","author":"M Jiang","year":"2014","unstructured":"Jiang M, Zheng J, Peng Q, Hou Z, Zhang J, Mori S, Ellis JL, Vlasuk GP et al (2014) Sirtuin 1 activator SRT 2104 protects Huntington's disease mice. Ann Clin Transl Neurol 1:1047\u20131052. https:\/\/doi.org\/10.1002\/acn3.135","journal-title":"Ann Clin Transl Neurol"},{"key":"2387_CR66","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.tips.2012.05.007","volume":"33","author":"G Donmez","year":"2012","unstructured":"Donmez G (2012) The neurobiology of sirtuins and their role in neurodegeneration. Trends Pharmacol Sci 33:494\u2013501. https:\/\/doi.org\/10.1016\/j.tips.2012.05.007","journal-title":"Trends Pharmacol Sci"},{"key":"2387_CR67","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","volume":"127","author":"L Cui","year":"2006","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1\u03b1 by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59\u201369. https:\/\/doi.org\/10.1016\/j.cell.2006.09.015","journal-title":"Cell"},{"key":"2387_CR68","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","volume":"4","author":"P Weydt","year":"2006","unstructured":"Weydt P, Pineda VV, Torrence AE, Libby RT, Satterfield TF, Lazarowski ER, Gilbert ML, Morton GJ et al (2006) Thermoregulatory and metabolic defects in Huntington\u2019s disease transgenic mice implicate PGC-1\u03b1 in Huntington's disease neurodegeneration. Cell Metab 4:349\u2013362. https:\/\/doi.org\/10.1016\/j.cmet.2006.10.004","journal-title":"Cell Metab"},{"key":"2387_CR69","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbadis.2008.02.010","volume":"1782","author":"TF Outeiro","year":"2008","unstructured":"Outeiro TF, Marques O, Kazantsev A (2008) Therapeutic role of sirtuins in neurodegenerative disease. Biochimi Biophys Acta (BBA)-Mol Basis Dis 1782:363\u2013369. https:\/\/doi.org\/10.1016\/j.bbadis.2008.02.010","journal-title":"Biochimi Biophys Acta (BBA)-Mol Basis Dis"},{"key":"2387_CR70","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.chembiol.2016.05.015","volume":"23","author":"L Quinti","year":"2016","unstructured":"Quinti L, Casale M, Moniot S, Pais TF, Van Kanegan MJ, Kaltenbach LS, Pallos J, Lim RG et al (2016) SIRT2-and NRF2-targeting thiazole-containing compound with therapeutic activity in Huntington\u2019s disease models. Cell Chem Biol 23:849\u2013861. https:\/\/doi.org\/10.1016\/j.chembiol.2016.05.015","journal-title":"Cell Chem Biol"},{"key":"2387_CR71","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/bcp.12512","volume":"79","author":"SD S\u00fcssmuth","year":"2015","unstructured":"S\u00fcssmuth SD, Haider S, Landwehrmeyer GB, Farmer R, Frost C, Tripepi G, Andersen CA, Di Bacco M et al (2015) An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington\u2019s disease. Br J Clin Pharmacol 79:465\u2013476. https:\/\/doi.org\/10.1111\/bcp.12512","journal-title":"Br J Clin Pharmacol"},{"key":"2387_CR72","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.expneurol.2010.05.006","volume":"225","author":"DJ Ho","year":"2010","unstructured":"Ho DJ, Calingasan NY, Wille E, Dumont M, Beal MF (2010) Resveratrol protects against peripheral deficits in a mouse model of Huntington\u2019s disease. Exp Neurol 225:74\u201384. https:\/\/doi.org\/10.1016\/j.expneurol.2010.05.006","journal-title":"Exp Neurol"},{"key":"2387_CR73","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/00008877-200609000-00014","volume":"17","author":"P Kumar","year":"2006","unstructured":"Kumar P, Padi SSV, Naidu PS, Kumar A (2006) Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms. Behav Pharmacol 17:485\u2013492. https:\/\/doi.org\/10.1097\/00008877-200609000-00014","journal-title":"Behav Pharmacol"},{"key":"2387_CR74","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nm.2558","volume":"18","author":"M Jiang","year":"2012","unstructured":"Jiang M, Wang J, Fu J, Du L, Jeong H, West T, Xiang L, Peng Q et al (2012) Neuroprotective role of Sirt1 in mammalian models of Huntington\u2019s disease through activation of multiple Sirt1 targets. Nat Med 18:153\u2013158. https:\/\/doi.org\/10.1038\/nm.2558","journal-title":"Nat Med"},{"key":"2387_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nm.2559","volume":"18","author":"H Jeong","year":"2012","unstructured":"Jeong H, Cohen DE, Cui L, Supinski A, Savas JN, Mazzulli JR, Yates JR, Bordone L et al (2012) Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med 18:159\u2013165. https:\/\/doi.org\/10.1038\/nm.2559","journal-title":"Nat Med"},{"key":"2387_CR76","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","volume":"17","author":"J Pallos","year":"2008","unstructured":"Pallos J, Bodai L, Lukacsovich T, Purcell JM, Steffan JS, Thompson LM, Marsh JL (2008) Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease. Hum Mol Genet 17:3767\u20133775. https:\/\/doi.org\/10.1093\/hmg\/ddn273","journal-title":"Hum Mol Genet"},{"key":"2387_CR77","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1161\/strokeaha.114.004889","volume":"45","author":"NM Robbins","year":"2014","unstructured":"Robbins NM, Swanson RA (2014) Opposing effects of glucose on stroke and reperfusion injury: acidosis, oxidative stress, and energy metabolism. Stroke 45:1881\u20131886. https:\/\/doi.org\/10.1161\/strokeaha.114.004889","journal-title":"Stroke"},{"key":"2387_CR78","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/nm1735","volume":"14","author":"EH Lo","year":"2008","unstructured":"Lo EH (2008) A new penumbra: transitioning from injury into repair after stroke. Nat Med 14:497\u2013500","journal-title":"Nat Med"},{"key":"2387_CR79","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1134\/S1990747819040093","volume":"33","author":"S Schweizer","year":"2013","unstructured":"Schweizer S, Meisel A, M\u00e4rschenz S (2013) Epigenetic mechanisms in cerebral ischemia. J Cereb Blood Flow Metab 33:1335\u20131346. https:\/\/doi.org\/10.1134\/S1990747819040093","journal-title":"J Cereb Blood Flow Metab"},{"key":"2387_CR80","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1111\/j.1471-4159.2010.06993.x","volume":"115","author":"CL Gibson","year":"2010","unstructured":"Gibson CL, Murphy SP (2010) Benefits of histone deacetylase inhibitors for acute brain injury: a systematic review of animal studies. J Neurochem 115:806\u2013813. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06993.x","journal-title":"J Neurochem"},{"key":"2387_CR81","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s13311-013-0201-x","volume":"10","author":"S Baltan","year":"2013","unstructured":"Baltan S, Morrison RS, Murphy SP (2013) Novel protective effects of histone deacetylase inhibition on stroke and white matter ischemic injury. Neurotherapeutics 10:798\u2013807. https:\/\/doi.org\/10.1007\/s13311-013-0201-x","journal-title":"Neurotherapeutics"},{"key":"2387_CR82","doi-asserted-by":"publisher","first-page":"4273","DOI":"10.3390\/nu6104273","volume":"6","author":"SA Bassett","year":"2014","unstructured":"Bassett SA, Barnett MP (2014) The role of dietary histone deacetylases (HDACs) inhibitors in health and disease. Nutrients 6:4273\u20134301. https:\/\/doi.org\/10.3390\/nu6104273","journal-title":"Nutrients"},{"key":"2387_CR83","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s12975-017-0603-x","volume":"10","author":"R Verma","year":"2019","unstructured":"Verma R, Ritzel RM, Crapser J, Friedler BD, McCullough LD (2019) Evaluation of the neuroprotective effect of Sirt3 in experimental stroke. Transl Stroke Res 10:57\u201366. https:\/\/doi.org\/10.1007\/s12975-017-0603-x","journal-title":"Transl Stroke Res"},{"key":"2387_CR84","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/j.bbapap.2016.06.007","volume":"1864","author":"A Drazic","year":"2016","unstructured":"Drazic A, Myklebust LM, Ree R, Arnesen T (2016) The world of protein acetylation. Biochim Biophys Acta (BBA)-Proteins and. Proteomics 1864:1372\u20131401. https:\/\/doi.org\/10.1016\/j.bbapap.2016.06.007","journal-title":"Proteomics"},{"key":"2387_CR85","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1161\/strokeaha.113.001715","volume":"44","author":"M Hern\u00e1ndez-Jim\u00e9nez","year":"2013","unstructured":"Hern\u00e1ndez-Jim\u00e9nez M, Hurtado O, Cuartero MI, Ballesteros I, Moraga A, Pradillo JM, McBurney MW, Lizasoain I et al (2013) Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke 44:2333\u20132337. https:\/\/doi.org\/10.1161\/strokeaha.113.001715","journal-title":"Stroke"},{"key":"2387_CR86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/21691401.2019.1699831","volume":"366","author":"W Zhang","year":"2017","unstructured":"Zhang W, Wei R, Zhang L, Tan Y, Qian C (2017) Sirtuin 6 protects the brain from cerebral ischemia\/reperfusion injury through NRF2 activation. Neurosci 366:95\u2013104. https:\/\/doi.org\/10.1080\/21691401.2019.1699831","journal-title":"Neurosci"},{"key":"2387_CR87","doi-asserted-by":"publisher","first-page":"9188","DOI":"10.1007\/s12035-018-1058-0","volume":"55","author":"DT She","year":"2018","unstructured":"She DT, Wong LJ, Baik SH, Arumugam TV (2018) SIRT2 inhibition confers neuroprotection by downregulation of FOXO3a and MAPK signaling pathways in ischemic stroke. Mol Neurobiol 55:9188\u20139203. https:\/\/doi.org\/10.1007\/s12035-018-1058-0","journal-title":"Mol Neurobiol"},{"key":"2387_CR88","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jvs.2008.04.007","volume":"48","author":"W Dong","year":"2008","unstructured":"Dong W, Li N, Gao D, Zhen H, Zhang X, Li F (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 48:709\u2013714. https:\/\/doi.org\/10.1016\/j.jvs.2008.04.007","journal-title":"J Vasc Surg"},{"key":"2387_CR89","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2010.03.017","volume":"59","author":"HR Zhu","year":"2010","unstructured":"Zhu HR, Wang ZY, Zhu XL, Wu XX, Li EG, Xu Y (2010) Icariin protects against brain injury by enhancing SIRT1-dependent PGC-1\u03b1 expression in experimental stroke. Neuropharmacol 59:70\u201376. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.03.017","journal-title":"Neuropharmacol"},{"key":"2387_CR90","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2019.00025","volume":"12","author":"A Prasad","year":"2019","unstructured":"Prasad A, Bharathi V, Sivalingam V, Girdhar A, Patel BK (2019) Molecular mechanisms of TDP-43 misfolding and pathology in amyotrophic lateral sclerosis. Front Mol Neurosci 12:25. https:\/\/doi.org\/10.3389\/fnmol.2019.00025","journal-title":"Front Mol Neurosci"},{"key":"2387_CR91","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/cr.2013.94","volume":"23","author":"GM Pasinetti","year":"2013","unstructured":"Pasinetti GM, Bilski AE, Zhao W (2013) Sirtuins as therapeutic targets of ALS. Cell Res 23:1073\u20131074. https:\/\/doi.org\/10.1038\/cr.2013.94","journal-title":"Cell Res"},{"key":"2387_CR92","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.bbadis.2006.01.004","volume":"1762","author":"F Gros-Louis","year":"2006","unstructured":"Gros-Louis F, Gaspar C, Rouleau GA (2006) Genetics of familial and sporadic amyotrophic lateral sclerosis. Biochim Biophys Acta (BBA)-Mol Basis Dis 1762:956\u2013972. https:\/\/doi.org\/10.1016\/j.bbadis.2006.01.004","journal-title":"Biochim Biophys Acta (BBA)-Mol Basis Dis"},{"key":"2387_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/483501","volume":"2014","author":"L Song","year":"2014","unstructured":"Song L, Chen L, Zhang X, Li J (2014) Le W (2014) Resveratrol ameliorates motor neuron degeneration and improves survival in SOD1G93A mouse model of amyotrophic lateral sclerosis. Biomed Res Int 2014:1\u201310. https:\/\/doi.org\/10.1155\/2014\/483501","journal-title":"Biomed Res Int"},{"key":"2387_CR94","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1089\/jmf.2009.0243","volume":"13","author":"CD Markert","year":"2010","unstructured":"Markert CD, Kim E, Gifondorwa DJ, Childers MK, Milligan CE (2010) A single-dose resveratrol treatment in a mouse model of amyotrophic lateral sclerosis. J Med Food 13:1081\u20131085. https:\/\/doi.org\/10.1089\/jmf.2009.0243","journal-title":"J Med Food"},{"key":"2387_CR95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000329724","volume":"9","author":"A Raghavan","year":"2012","unstructured":"Raghavan A, Shah ZA (2012) Sirtuins in neurodegenerative diseases: a biological-chemical perspective. Neurodegener Dis 9:1\u201310. https:\/\/doi.org\/10.1159\/000329724","journal-title":"Neurodegener Dis"},{"key":"2387_CR96","doi-asserted-by":"publisher","first-page":"0116919","DOI":"10.1371\/journal.pone.0116919","volume":"10","author":"X Chen","year":"2015","unstructured":"Chen X, Wales P, Quinti L, Zuo F, Moniot S, Herisson F, Rauf NA, Wang H et al (2015) The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson\u2019s disease but not amyotrophic lateral sclerosis and cerebral ischemia. PLoS One 10:0116919. https:\/\/doi.org\/10.1371\/journal.pone.0116919","journal-title":"PLoS One"},{"key":"2387_CR97","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","volume":"22","author":"I Taes","year":"2013","unstructured":"Taes I, Timmers M, Hersmus N, Bento-Abreu A, Van Den Bosch L, Van Damme P, Auwerx J, Robberecht W (2013) Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum Mol Genet 22:1783\u20131790. https:\/\/doi.org\/10.1093\/hmg\/ddt028","journal-title":"Hum Mol Genet"},{"key":"2387_CR98","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/s1097-2765(03)00038-8","volume":"11","author":"BJ North","year":"2003","unstructured":"North BJ, Marshall BL, Borra MT, Denu JM, Verdin E (2003) The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 11:437\u2013444. https:\/\/doi.org\/10.1016\/s1097-2765(03)00038-8","journal-title":"Mol Cell"},{"key":"2387_CR99","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1371\/journal.pone.0000784","volume":"2","author":"BJ North","year":"2007","unstructured":"North BJ, Verdin E (2007) Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis. PLoS One 2:784. https:\/\/doi.org\/10.1371\/journal.pone.0000784","journal-title":"PLoS One"},{"key":"2387_CR100","doi-asserted-by":"publisher","first-page":"6823","DOI":"10.1074\/jbc.m609554200","volume":"282","author":"M Tanno","year":"2007","unstructured":"Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282:6823\u20136832. https:\/\/doi.org\/10.1074\/jbc.m609554200","journal-title":"J Biol Chem"},{"key":"2387_CR101","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.1098014","volume":"305","author":"T Araki","year":"2004","unstructured":"Araki T, Sasaki Y, Milbrandt J (2004) Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Sci 305:1010\u20131013. https:\/\/doi.org\/10.1126\/science.1098014","journal-title":"Sci"},{"key":"2387_CR102","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.pharmthera.2018.03.004","volume":"38","author":"JM Villalba","year":"2012","unstructured":"Villalba JM, Alca\u00edn FJ (2012) Sirtuin activators and inhibitors. Biofactors 38:349\u2013359. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.03.004","journal-title":"Biofactors"},{"key":"2387_CR103","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-016-0224-3","volume":"8","author":"V Carafa","year":"2016","unstructured":"Carafa V, Rotili D, Forgione M, Cuomo F, Serretiello E, Hailu GS, Jarho E, Lahtela-Kakkonen M et al (2016) Sirtuin functions and modulation: from chemistry to the clinic. Clin Epigenetics 8:61. https:\/\/doi.org\/10.1186\/s13148-016-0224-3","journal-title":"Clin Epigenetics"},{"key":"2387_CR104","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1158\/0008-5472.can-05-3617","volume":"66","author":"B Heltweg","year":"2006","unstructured":"Heltweg B, Gatbonton T, Schuler AD, Posakony J, Li H, Goehle S, Kollipara R, DePinho RA et al (2006) Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res 66:4368\u20134377. https:\/\/doi.org\/10.1158\/0008-5472.can-05-3617","journal-title":"Cancer Res"},{"key":"2387_CR105","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.3390\/ijms21072601","volume":"21","author":"S Zhao","year":"2020","unstructured":"Zhao S, Zhu YY, Wang XY, Liu YS, Sun YX, Zhao QJ, Li HY (2020) Structural Insight into the Interactions between structurally similar inhibitors and SIRT6. Int J Mol Sci 21:2601. https:\/\/doi.org\/10.3390\/ijms21072601","journal-title":"Int J Mol Sci"},{"key":"2387_CR106","doi-asserted-by":"publisher","first-page":"666","DOI":"10.2174\/1389450111314060008","volume":"14","author":"C Chakraborty","year":"2013","unstructured":"Chakraborty C (2013) Sirtuins family-recent development as a drug target for aging, metabolism, and age related diseases. Curr Drug Targets 14:666\u2013675. https:\/\/doi.org\/10.2174\/1389450111314060008","journal-title":"Curr Drug Targets"},{"key":"2387_CR107","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3389\/fnagi.2014.00184","volume":"6","author":"L Liu","year":"2014","unstructured":"Liu L, Arun A, Ellis L, Peritore C, Donmez G (2014) SIRT2 enhances 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced nigrostriatal damage via apoptotic pathway. Front Aging Neurosci 6:184. https:\/\/doi.org\/10.3389\/fnagi.2014.00184","journal-title":"Front Aging Neurosci"},{"key":"2387_CR108","doi-asserted-by":"publisher","first-page":"12630","DOI":"10.1523\/jneurosci.0277-12.2012","volume":"32","author":"JA Parker","year":"2012","unstructured":"Parker JA, Vazquez-Manrique RP, Tourette C, Farina F, Offner N, Mukhopadhyay A, Orfila AM, Darbois A et al (2012) Integration of \u03b2-catenin, sirtuin, and FOXO signaling protects from mutant huntingtin toxicity. J Neurosci 32:12630\u201312640. https:\/\/doi.org\/10.1523\/jneurosci.0277-12.2012","journal-title":"J Neurosci"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02387-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-021-02387-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-021-02387-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T03:47:43Z","timestamp":1626320863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-021-02387-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":108,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2387"],"URL":"https:\/\/doi.org\/10.1007\/s12035-021-02387-w","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}